Research into the immunopathogensis of chronic bacterial colonisation of cystic fibrosis (CF) patients has been hampered by lack of a suitable animal model. Whilst models of chronic infection have been described, they rely on the use of artificial embedding material to prevent rapid clearance of the bacteria. We hypothesised that careful selection of the bacterial isolate, mouse strain and infection regime, will result in a clinically relevant murine model of chronic S. aureus (SA) and P. aeruginosa (PA) infection without the need for embedding materials. Previously published models have largely used PA01 and lab attenuated SA strains. We have screened several hundred clinical isolates of SA and PA and selected 5 strains of each for murine infection experiments, based on genotype and phenotype. The selected SA isolates include haemolytic strains from CF and non-CF sputum. The PA isolates originated from CF or ICU patients and were selected based on phenotype including ability to form biofilm in vitro. Significant differences in the in vivo virulence of these strains have been shown. Equally essential is mouse strain. C57BL6 mice are used almost exclusively, however this strain are inherently resistant to bacterial infection. We have compared the survival and colonisation of C57BL6, A/J, BALBc, Biozzi, FVB/N, NIH, SJL, CD1, MF1 and NMRI female mice with PA and SA. Identifying a combination of mouse and bacterial strain resulting in the prolonged survival of the animal whilst maintaining chronic pulmonary infection, will allow investigation of the intricate immunological and physiological disease processes involved during chronic pulmonary infection of CF patients.
Research into the immunopathogensis of chronic bacterial colonisation of cystic fibrosis (CF) patients has been hampered by lack of a suitable animal model. Whilst models of chronic infection have been described, they rely on the use of artificial embedding material to prevent rapid clearance of the bacteria. We hypothesised that careful selection of the bacterial isolate, mouse strain and infection regime, will result in a clinically relevant murine model of chronic S. aureus (SA) and P. aeruginosa (PA) infection without the need for embedding materials. Previously published models have largely used PA01 and lab attenuated SA strains. We have screened several hundred clinical isolates of SA and PA and selected 5 strains of each for murine infection experiments, based on genotype and phenotype. The selected SA isolates include haemolytic strains from CF and non-CF sputum. The PA isolates originated from CF or ICU patients and were selected based on phenotype including ability to form biofilm in vitro. Significant differences in the in vivo virulence of these strains have been shown. Equally essential is mouse strain. C57BL6 mice are used almost exclusively, however this strain are inherently resistant to bacterial infection. We have compared the survival and colonisation of C57BL6, A/J, BALBc, Biozzi, FVB/N, NIH, SJL, CD1, MF1 and NMRI female mice with PA and SA. Identifying a combination of mouse and bacterial strain resulting in the prolonged survival of the animal whilst maintaining chronic pulmonary infection, will allow investigation of the intricate immunological and physiological disease processes involved during chronic pulmonary infection of CF patients. Burkholderia cepacia complex (Bcc) members are associated with patient mortality in CF as they may induce 'cepacia syndrome', an acute deterioration of lung function with associated septicaemia. Most Bcc species are multi-drug-resistant and form biofilms, further reducing their antibiotic susceptibility. To ascertain whether Bcc biofilm formation confers advantages to the pathogen by evading host cell responses, we examined the interaction of neutrophils with Bcc biofilms in vitro. Confocal microscopy demonstrated that biofilm formation protected Bcc species from phagocytosis, illustrating that differentiated, neutrophil-like HL60 cells (dHL60s) remain at the exterior surface of Bcc biofilms >2h post-inoculation, impeding phagocytosis. Planktonic Bcc bacteria did form significantly less biofilm, up to 72h after inoculation, when initially inoculated in tandem with dHL60s (p < 0.05); however when added to biofilms already established for 24−72h, dHL60s lead to an increase in biofilm density. Neutrophils undergo apoptosis and disintegrate shortly after recruitment to the lung and repeat experiments demonstrated that wholecell lysates of dHL60 also increased the density of established biofilms (48h). Interestingly, dHL60s secreted significant quantities of IL-8 <1h after contact with Bcc biofilm (p < 0.05), but degranulated less when added to older biofilms (48−72h). Hence, biofilms facilitate Bcc species persistence in the CF lung and the presence of neutrophils reinforces that biofilm. Therefore, strategies to improve neutrophil efficacy in clearing colonising Bcc must focus on overcoming biofilm-mediated resistance. This work is funded by Science Foundation Ireland (SFI).
